Cited 0 time in
- Title
- N-메틸렌나프토[2,1-b]퓨란-2-카보하이드라지드 유도체를 유효성분으로 포함하는 암 예방 또는 치료용 조성물
- Alternative Title
- Anti cancer and prevention Activity of (E)-ethyl 2-(2-methyl-3-((2-(naphtho[2,1-b]furan-2-carbonyl)hydrazono)methyl)-1H-indol-1-yl)acetate, a Novel Small Molecule Tubulin Inhibitor
- Inventor(s)
- 안종석; 김보연; 장재혁; 성낙균; 크리사다; 류인자; 김선옥; 띠메오고단; 황준성
- Assignee(s)
- 한국생명공학연구원
- Application No.
- 14/641,065 (2015.03.06)
- Registration No.
- 9,433,607 (2016.09.06)
- Country
- 미국
- Abstract
- The present invention relates to ethyl(2-methyl-3{(E)-[(naphtho[2,1-b]furan-2-ylcarbonyl)hydrazono]methyl}-1H-indole-1-yl)acetate, the novel mitosis inhibitor. The said ethyl(2-methyl-3{(E)-[(naphtho[2,1-b]furan-2-ylcarbonyl)hydrazono]methyl}-1H-indole-1-yl)acetate not only induces apoptosis by inhibiting tubulin polymerization in the course of mitosis but also displays an excellent anticancer effect in the multi-drug resistant cancer cells, so that it can be effectively used for the treatment of cell proliferative disease including various cancers.
- Type
- Patent
- Appears in Collections:
- Ochang Branch Institute > Chemical Biology Research Center > 2. Patents
- Files in This Item:
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.